Main Menu

IDG Events

2021-09-16: e-IDG Symposium: Inaugural Fall session in this series focuses on Kinases with presentation by Dr. Susan Taylor (UCSD) and Dr. Jinae Roa (UCSD) on "Retina: window into PKA signaling Neurons", and by IDG speaker, Dr. Stephan Schürer (UofMiami) on "The Dark Cancer Kinome: Untapped Opportunities to Target Understudied Kinases in Cancer". Register here: |Read More|

2021-08-10: FASEB Science Research Conference: Dr. Lily Jan, UCSF, and Dr. Bryan Roth, UNC, are organizing “The Understudied Druggable Proteome Conference” as part of the FASEB series (#UCP21). This conference is focused on exploring the understudied druggable proteome and will bring together pharmacologists, chemical biologists, biochemists, physiologists, and system biologists. The keynote lecture will be given by Dr. Ardem Patapoutian, Howard Hughes Medical Institute and Scripps Research Insistute. This virtual conference will take place August 10-12, 2021. |Read More|

2021-05-18: IDG e-Symposium Series: The final session of the IDG e-Symposium Series will finish strong by highlighting outcomes from IDG-associated R03 grants focused on GPCR with presentations by Dr. Thomas Green, PhD, University of Texas Medical Branch, "GPR12 in the nucleus accumbens and addiction: electrophysiology and behavior" andDr. Daniel G. Isom, PhD, University of Miami Miller School of Medicine, "Illuminating how dark GPCRs detect protons". To Register: |Read More|

2021-05-04: IDG e-Symposium Series: The IDG s-symposium series continues with a session on Informatics Tools with presentations by Dr. Paul W. Sternberg, PhD, CalTech, "Curating, integrating and presenting information about model organisms at the Alliance of Genome Resources" and by Dr. Lincoln Stein, MD PhD, OICR and co-PI of Reactome, "Guilt by Association: A Few Tricks for Finding and Characterizing Cancer-Associated Genes". To Register: |Read More|

2021-04-20: IDG e-Symposium Series: Ion Channels are the focus of the fourth installment of this series with invited speaker, Dr. Srinivas Niranj Chandrasekaran, PhD, Broad Institute, "Accelerating drug discovery with the power of microscopy" and IDG speaker, Dr. Stefan Feske, MD, New York University School of Medicine, "Identification of novel ion channels and transporters in immune cells". To Register: |Read More|

2021-04-06: IDG e-Symposium Series: This session will focus on GPCR with presentations by invited speaker, Dr. Aashish Manglik, PhD, University of California San Francisco, "Fishing with new bait: biochemical approaches to interrogate orphan GPCR function" and and by IDG speaker, Dr. Can Cao, DRGC-GPCR, "Structural and functional study of orphan receptor". To Register: |Read More|

2021-03-30: IDG e-Symposium Series: Second session in this series focuses on Kinases with presentations by invited speaker, Dr. Martin Golkowski, University of Washington, on "Targeting Phenotypic Transitions to Overcome Cancer Metastasis and Therapy Resistance" and by IDG speaker, Dr. Gary Johnson, PI for DRGC-Kinase, on “Plasticity of the Human Kinome Responding to Targeted Kinase Inhibition”. Register here: |Read More|

2021-03-16: IDG e-Symposium Series: The series will showcase two speakers (external and IDG) sharing new developments of experimental resources and digital tools illuminating the understudied targets in three main druggable protein families: GPCR, kinase and ion channels... and beyond. This session 1 theme is Informatics platforms and Drug Discovery with Invited speaker: Dr. Ian Dunham, Director of Open Targets at EMBL-EBI, "Identifying and prioritising drug targets with the Open Targets Platform and Open Targets Genetics" and IDG speaker: Dr. Tudor Oprea, PI for KMC and RDOC, "Illuminating the Druggable Genome: Drugs, Targets, Phenotypes and Diseases". Register here: |Read More|

2020-10-26: ATOM-IDG Symposium Series: The goal for this outreach event is to explore collaborative activities via a joint symposium that would promote development of drugs from IDG probes. ATOM (Accelerating Therapeutics for Opportunities in Medicine) is a consortium of National Labs, Biotech/Pharma Companies and UCSF. The objective of ATOM is to transform drug discovery from experiment-driven, sequential, and high-failure to computation-driven, integrated and patient-centric. |Read More|

2020-09-10: IDG OUTREACH Meeting UNC: This symposium is aimed toward participants interested in target selection in drug discovery, expansion of protein function, development of experimental and informatics approaches to understanding proteins, as well as potential collaborators from academia, industry and not-for-profit institutes. It was held virtually on Thursday, September 10th and Friday September 11th, 2020. |Read More|

2019-11-15: Finding Targets for Drug Discovery - A joint symposium hosted by Open Targets and Illuminating the Druggable Genome consortium highlighting their work to expand knowledge and experimental data to enable new targets in drug discovery. |Read More or view a pdf of the public summary|

2018-08-23: IDG Outreach meeting with BAGIM (Boston Area Group for Informatics and Modeling) at Harvard University, covering presentation from IDG members. |Read More|

2018-08-22: Move Away from the Lamppost & Find Druggable Targets, an ACS symposium at the Fall 2018 ACS National Meeting & Exposition in Boston, MA, was organized by Dr. Rajarshi Guha (Vertex) and Dr. Tudor Oprea (UNM, KMC) for August 22, 2018. |Read More|